Healthy Skepticism Library item: 1957
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: news
Croasdale M.
Drug firms to fund residency slots in dermatology pilot program
American Medical Association ( AMA News) 2005 Jul 18
http://www.amednews.com/2005/prl20718
Abstract:
DRUG FIRMS TO FUND RESIDENCY SLOTS IN DERMATOLOGY PILOT PROGRAM
Ethicists express concerns about inherent conflicts of interest in such
a relationship.
By Myrle Croasdale, July 18, 2005.
Faced with a work-force shortage and no new federal funding for resident
training, the American Academy of Dermatology is expanding residency
slots by using pharmaceutical company donations. AAD leaders say enough
safeguards are in place to prevent conflicts of interest that could
arise from the relationship, but critics say such funding compromises
the medical profession and leaves it beholden to for-profit
corporations. The academy’s goal is to increase dermatology resident
positions by up to 10% — about 30 new slots — per year. A pilot
program will fund an initial 10 slots at $60,000 per slot per year for
three years starting in July 2006. […]
Read the entire article in American Medical News:
www.amednews.com/2005/prl20718
Notes:
Ralph Faggotter’s Comments: What hope is there for independence of thought when your specialist training position is being funded by a drug company?
Why would a drug company pay for this training if they didn’t expect a good return on their investment?
